Full-Time

Head of Toxicology

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

No salary listed

Senior, Expert

Cambridge, MA, USA

The job follows a 70/30 in-office work model, indicating that 70% of the time is expected to be in the office.

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • PhD & 15 or more years spent overseeing aspects of nonclinical safety assessment activities in pharmaceutical development. Strong consideration will be given to those with experience in nucleic acid-based and nanoparticle modalities, immune-modulating therapeutics, oncology, and/or infectious disease vaccine drug development.
  • A distinguished reputation in the global scientific community as a Toxicology expert.
  • Experience serving in/managing colleagues serving in the capacity of a Toxicology representative on drug development programs in the pharmaceutical/biotechnology industry and corresponding experience in designing and executing nonclinical toxicology strategies and studies to support clinical development and marketing applications.
  • Experience in mentoring, coaching, and managing others on developing toxicology strategies.
  • Direct experience in writing, reviewing, and critiquing nonclinical sections of regulatory submission documents (e.g., INDs/CTAs/BLAs/MAAs, briefing documents, regulatory query responses) and interacting with regulatory agencies.
  • Familiarity with regulatory guidelines for the conduct of nonclinical safety studies to support regulatory filings.
  • Experience with and a passion for people management, team building, and creative solution seeking.
  • Outstanding written and verbal communication skills and the ability to develop and deliver clear and concise presentations for both internal and external stakeholders.
  • Attention to detail and quality, and ability to deliver work on time.
  • Demonstrated ability to work successfully in a fast-paced and dynamic work environment, with the agility to quickly pivot in the face of new data and/or strategic directions.
  • Experience in significantly impacting departmental and organizational initiatives that have shaped research strategies.
  • A desire to make an impact as part of a high-growth, transformational company that is Bold, Relentless, Curious, and Collaborative.
Responsibilities
  • In alignment with the corporate mindsets, provide strategic leadership and direction for and build capabilities of the Toxicology team to execute on Moderna's ambitious and dynamic agenda to deliver transformational medicines and vaccines to patients.
  • Apply in-depth knowledge of how toxicology disciplines (including but not limited to general toxicology, safety pharmacology, genotoxicity, developmental and reproductive toxicology, and carcinogenicity) integrate with other areas across the business and utilize business/market expertise to differentiate Moderna from the competition.
  • Evaluate toxicology challenges in a complex or fast-changing environment and direct the development of new or innovative solutions with in-depth analysis and interpretive thinking.
  • Lead and manage a team of toxicologists across a range of job levels and experience (may include people leaders), fostering a culture of innovation, collaboration, functional excellence, and continuous learning and development within the team, supporting career growth and professional development opportunities for team members.
  • In conjunction with platform and pipeline program teams and a cross-functional and integrated Nonclinical Drug Development Sciences team, provide strategic oversight on and coach/guide team members on the development of scientifically-sound toxicology strategies to provide expert support to discovery and development projects.
  • Accountable for the design, execution, and critical analysis of nonclinical safety in vitro and/or in vivo studies conducted in multiple species under the Toxicology umbrella via collaborative partnerships with study monitors and other partner line program representatives (e.g., pathology, DMPK, bioanalytical, operations, etc.). Accountable for toxicology assessments supporting extractable/leachable and contaminant risk assessments and/or impurity qualification.
  • Collaborate closely with and establish positive working relationships with leaders of/colleagues from other nonclinical disciplines (e.g., pathology, DMPK, bioanalytical, therapeutic and infectious disease research, study management & outsourcing, writing, strategic operations) to deliver on integrated nonclinical safety data packages for programs, as well as with clinical development and safety colleagues when interpreting nonclinical data as it pertains to active clinical pipeline programs.
  • Provide strategic advice to project teams and senior management including evaluation of conclusions and impact of study results on program and clinical/regulatory strategy.
  • Apply expert scientific and regulatory writing experience when critically reviewing, editing, and authoring submission application documents (INDs, CTAs, BLAs and MAAs) and health authority interaction documents (e.g., briefing documents, regulatory query responses) and integrate results with DMPK and pharmacology. Ensure alignment of toxicology with clinical development plans and regulatory strategies.
  • Oversee the preparation and presentation of nonclinical safety data for project teams, portfolio management, internal/external partners and/or scientific groups.
  • Maintain extensive scientific awareness and presence internally and externally, leading initiatives to publish manuscripts and posters, present at scientific conferences and other scientific forums, engage with consultants and advisors in the field, as well as the scientific community at large.
  • In addition to serving as Head of the Toxicology line function, the incumbent may also serve as an independent contributor for a select number of discovery and/or pipeline programs as a Toxicology representative.
Desired Qualifications
  • Experience in significantly impacting departmental and organizational initiatives that have shaped research strategies.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional methods of drug development, Moderna's use of mRNA allows for a more flexible and efficient process in discovering and manufacturing medicines. The company's goal is to harness the power of mRNA to improve patient outcomes and create a new category of therapies that can address a wide range of health issues.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Cambridge, Massachusetts

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's RSV vaccine received regulatory approval in Australia, expanding its infectious disease portfolio.
  • The collaboration with Merck on personalized cancer vaccines shows promising early trial results.
  • Moderna's mRNA technology is gaining traction in personalized medicine and infectious disease prevention.

What critics are saying

  • Moderna faces reputational damage from a bribery scandal related to COVID-19 vaccine trials.
  • HHS funding cancellation for bird flu vaccine development may impact Moderna's revenue streams.
  • Regulatory delays could slow down Moderna's product pipeline and affect its competitive edge.

What makes Moderna unique

  • Moderna is pioneering mRNA technology as a new class of medicines.
  • The company collaborates with IBM Quantum to enhance mRNA drug design using quantum computing.
  • Moderna's AI-driven research partnership with Benchling highlights its innovative approach to drug discovery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

401(k) Company Match

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

4%
Meet the People
Jun 2nd, 2025
Social Media Campaign of the Year - Healthcare Marketing Impact Awards

Meet The People, LLC is delighted to share that Coegi's SpikevaxPartner campaign with Moderna has been recognized as a Social Media Campaign of the Year in the 2024 Healthcare Marketing Impact Awards by Modern Healthcare and Ad Age!

The Washington Post
May 28th, 2025
HHS cancels funding for Moderna to develop vaccines to combat bird flu

HHS cancels funding for Moderna to develop vaccines to combat bird flu.

FermionIQ
May 20th, 2025
Quantum-centric workflows for predicting RNA secondary structure

In a recent collaboration with Moderna and IBM Quantum, Fermioniq developed two quantum-centric optimization algorithms to predict mRNA secondary structure - a key challenge in computational biology with direct implications for mRNA-based drug design.

Things of Business
May 7th, 2025
Benchling and Moderna Collaborate on AI-Driven Research

SAN FRANCISCO and BOSTON, May 7, 2025 - Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna.

Parriva
May 6th, 2025
Flesh-Eating Bacteria Surge in California: What You Need to Know

Moderna is reportedly working on a candidate vaccine using similar mRNA technology to its COVID-19 formula, but experts express concern about regulatory delays.